Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 2 - The Real Truth

Medtronic Kicks Off US Study On Robot-Assisted Surgeries For Women

Medtronic plc (NYSE:MDT) Wednesday announced the commencement of the Embrace Gynecology investigational device exemption (IDE) U.S. clinical study to assess the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system in gynecological procedures.

Benzinga

Medtronic's New Implant Could Transform Bladder Control Treatment

Innovative medical technologies are transforming healthcare by tackling chronic conditions that affect millions, offering hope and improved quality of life. The Food and Drug Administration (FDA) approved Medtronic plc’s (NYSE:MDT) Altaviva device on Friday.

Benzinga

Medtronic's Hugo Robotic System Achieves 100% Success Rate In Hernia Repair Trial

Medtronic PLC (NYSE:MDT) released on Thursday results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo robotic-assisted surgery (RAS) system in inguinal and ventral hernia repair procedures.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic Stock: Is MDT Outperforming the Healthcare Sector?

Medtronic has significantly outperformed the broader healthcare sector over the past year and in recent months, and analysts remain bullish on the stock’s prospects.

Barchart

Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Medtronic Has Potential To Pursue Further Divestitures: Analyst

On Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's largest shareholder.

Benzinga

These Analysts Boost Their Forecasts On Medtronic After Upbeat Q1 Earnings

Medtronic plc (NYSE:MDT) posted better-than-expected earnings for the first quarter and announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Medtronic: The Opportunity Gets Healthier for Income Investors

Medtronic is on track to complete a market reversal in 2025. Sell-siders, including activists, analysts, and institutions, are buying this stock in 2025.

MarketBeat

Medtronic Lifts Annual Outlook, Appoints New Directors In Post-Elliott Strategic Shift

Medtronic plc (NYSE:MDT) announced key board appointments on Tuesday, naming John Groetelaars and Bill Jellison as independent directors, effective immediately. This move comes shortly after Elliott Investment Management became the company’s largest shareholder.

Benzinga

Stock Index Futures Muted as Focus Turns to Retail Earnings, U.S. Housing Data Awaited

September S&P 500 E-Mini futures (ESU25) are down -0.09%, and September Nasdaq 100 E-Mini futures (NQU25) are down -0.08% this morning as earnings from the nation’s retail heavyweights kicked off, shifting the focus to the strength of the American consumer.

Barchart

Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Medtronic plc (NYSE:MDT) will release financial results for the first quarter before the opening bell on Tuesday, Aug. 19.

Benzinga

Are Wall Street Analysts Bullish on Medtronic Stock?

While Medtronic has struggled to keep up with the broader market over the past year, analysts remain fairly upbeat on its future growth prospects.

Barchart

Former nurse loses legal challenge over registration of private gender clinic

Susan Evans and a mother known as XX challenged the regulator’s decision to continue the registration of the site in Birmingham.

Evening Standard

Here's What to Expect From Medtronic's Next Earnings Report

Medtronic is all set to release its fiscal first-quarter earnings later next month, and analysts project earnings in line with the year-ago quarter.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Court Nixes Jury Award Over Medtronic's Heart Valve Infringement Claim

A federal appeals court has sided with Medtronic Plc (NYSE:MDT) in a long-running patent dispute, reversing a jury's finding that the company induced infringement of a Colibri Heart Valve LLC patent related to the implantation of artificial heart valves.

MarketBeat

5 Robotics Stocks to Buy for the Future of Automation

Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing.

Evening Standard

Watchdog acted ‘irrationally’ in registering private gender clinic, court told

Two women are challenging the Care Quality Commission’s decision to register the Gender Plus Hormone Clinic in Birmingham.

Evening Standard

Further two inquests into deaths of rogue breast surgeon’s ex-patients opened

Ian Paterson is currently serving a 20-year prison sentence after being convicted for carrying out unapproved and unnecessary procedures on patients.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Why the Death Cross Could Be a Contrarian Signal for Medtronic (MDT)

Although MDT stock is about to flash an ominous technical indicator, quantitative-focused investors will want to keep Medtronic on their watch list.

Barchart

What Are Wall Street Analysts’ Target Price for Medtronic Stock?

While Medtronic has underperformed relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Is Zimmer Biomet Stock Outperforming the S&P 500?

Zimmer Biomet has recently surged past the S&P 500 Index, with analysts maintaining a cautiously upbeat outlook on its growth potential.

Barchart

Is Medtronic Stock Underperforming the Nasdaq?

Medtronic has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

MarketBeat

MarketBeat Week in Review – 02/17 - 02/21

Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news

StockNews.com

3 Healthcare IT Stocks Revolutionizing Patient Care

With healthcare rapidly evolving through digital transformation, the demand for smarter, more efficient solutions is rising, and companies driving this shift are poised for significant upside. Therefore, investors might find opportunities in fundamentally strong healthcare IT stocks like Medtronic (MDT), McKesson Corp. (MCK), and Embecta (EMBC). Read more….

Barchart

Medtronic Stock: Is Wall Street Bullish or Bearish?

Medtronic has underperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

1 2 3 4 5

People

Gabriel OsorioMazilli

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.